The University of Chicago Header Logo

Connection

Richard Whitley to Simplexvirus

Back to Details
This is a "connection" page, showing publications Richard Whitley has written about Simplexvirus.
Richard Whitley
Connection Strength
8.661
Simplexvirus
  1. Shedding Patterns of Genital Herpes Simplex Virus Infections. JAMA. 2022 11 01; 328(17):1710-1711.
    View in: PubMed
    Score: 0.813
  2. Herpes simplex virus. Handb Clin Neurol. 2014; 123:251-63.
    View in: PubMed
    Score: 0.441
  3. Viral therapy of glioblastoma multiforme. Proc Natl Acad Sci U S A. 2013 Jul 16; 110(29):11672-3.
    View in: PubMed
    Score: 0.426
  4. An inquiry into the molecular basis of HSV latency and reactivation. Annu Rev Microbiol. 2013; 67:355-74.
    View in: PubMed
    Score: 0.411
  5. Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12. J Virol. 2012 May; 86(9):5304-13.
    View in: PubMed
    Score: 0.388
  6. Neonatal herpes simplex virus infections: where are we now? Adv Exp Med Biol. 2011; 697:221-30.
    View in: PubMed
    Score: 0.358
  7. The incidence and severity of herpes simplex encephalitis in Sweden, 1990-2001. Clin Infect Dis. 2007 Oct 01; 45(7):881-2.
    View in: PubMed
    Score: 0.284
  8. Review of recent HSV recurrent-infection treatment studies. Herpes. 2007 Jun; 14(1):23-6.
    View in: PubMed
    Score: 0.279
  9. Herpes simplex encephalitis: adolescents and adults. Antiviral Res. 2006 Sep; 71(2-3):141-8.
    View in: PubMed
    Score: 0.259
  10. Genetically engineered herpes simplex viruses that express IL-12 or GM-CSF as vaccine candidates. Vaccine. 2006 Mar 06; 24(10):1644-52.
    View in: PubMed
    Score: 0.249
  11. HSV shedding. Antiviral Res. 2004 Aug; 63 Suppl 1:S19-26.
    View in: PubMed
    Score: 0.229
  12. Herpes simplex viruses: is a vaccine tenable? J Clin Invest. 2002 Jul; 110(2):145-51.
    View in: PubMed
    Score: 0.198
  13. Herpes simplex virus infection. Semin Pediatr Infect Dis. 2002 Jan; 13(1):6-11.
    View in: PubMed
    Score: 0.192
  14. Genetically engineered human herpes simplex virus in the treatment of brain tumours. Herpes. 2001 Mar; 8(1):17-22.
    View in: PubMed
    Score: 0.181
  15. The nine ages of herpes simplex virus. Herpes. 2001 Mar; 8(1):23-7.
    View in: PubMed
    Score: 0.181
  16. Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors. Hum Gene Ther. 2020 10; 31(19-20):1132-1139.
    View in: PubMed
    Score: 0.174
  17. Genetically engineered HSV in the treatment of glioma: a review. Rev Med Virol. 2000 Jan-Feb; 10(1):17-30.
    View in: PubMed
    Score: 0.167
  18. Herpes simplex viruses. Clin Infect Dis. 1998 Mar; 26(3):541-53; quiz 554-5.
    View in: PubMed
    Score: 0.147
  19. Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins. Gene Ther. 1998 Jan; 5(1):121-30.
    View in: PubMed
    Score: 0.145
  20. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1996 Dec; 174(6):1162-7.
    View in: PubMed
    Score: 0.135
  21. The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors. Proc Natl Acad Sci U S A. 1996 Oct 15; 93(21):11313-8.
    View in: PubMed
    Score: 0.134
  22. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1995 Apr; 171(4):857-63.
    View in: PubMed
    Score: 0.120
  23. Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. Proc Natl Acad Sci U S A. 1995 Feb 28; 92(5):1411-5.
    View in: PubMed
    Score: 0.119
  24. Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines. Gene Ther. 2014 Nov; 21(11):984-90.
    View in: PubMed
    Score: 0.115
  25. Prospects for vaccination against herpes simplex virus. Pediatr Ann. 1993 Dec; 22(12):726, 729-32.
    View in: PubMed
    Score: 0.110
  26. Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models. J Clin Invest. 1993 Jun; 91(6):2837-43.
    View in: PubMed
    Score: 0.106
  27. Neonatal herpes simplex virus infections: pathogenesis and therapy. Pathol Biol (Paris). 1992 Sep; 40(7):729-34.
    View in: PubMed
    Score: 0.100
  28. Prevalence of herpes simplex virus antibodies in dental students. J Dent Educ. 1992 Mar; 56(3):206-8.
    View in: PubMed
    Score: 0.097
  29. Herpes simplex vaccines. Biotechnology. 1992; 20:223-54.
    View in: PubMed
    Score: 0.096
  30. Expression of HSV-1 glycoproteins in tunicamycin-treated monkey kidney cells. Biochem Biophys Res Commun. 1990 Mar 30; 167(3):1139-45.
    View in: PubMed
    Score: 0.085
  31. A role for herpes simplex virus type 1 glycoprotein E in induction of cell fusion. J Gen Virol. 1989 Aug; 70 ( Pt 8):2157-62.
    View in: PubMed
    Score: 0.081
  32. Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA. 1989 Jul 14; 262(2):234-9.
    View in: PubMed
    Score: 0.081
  33. Effect of recombinant hybrid human interferon on replication and morphogenesis of HSV-1 in monkey cells. Virus Res. 1989 Jan; 12(1):33-41.
    View in: PubMed
    Score: 0.078
  34. Antibody response of the newborn after herpes simplex virus infection. J Infect Dis. 1988 Nov; 158(5):925-33.
    View in: PubMed
    Score: 0.077
  35. Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM. Mol Ther. 2009 Jan; 17(1):199-207.
    View in: PubMed
    Score: 0.077
  36. Detection and diagnosis of herpes simplex virus infection in adults with acute liver failure. Liver Transpl. 2008 Oct; 14(10):1498-504.
    View in: PubMed
    Score: 0.077
  37. Neurovirulence in an experimental focal herpes encephalitis: relationship to observed seizures. Brain Res. 1988 Feb 09; 440(2):293-8.
    View in: PubMed
    Score: 0.073
  38. Protection against herpetic ocular disease by immunotherapy with monoclonal antibodies to herpes simplex virus glycoproteins. Intervirology. 1988; 29(1):39-49.
    View in: PubMed
    Score: 0.073
  39. Detection of antigen to herpes simplex virus in cerebrospinal fluid from patients with herpes simplex encephalitis. J Infect Dis. 1987 Jun; 155(6):1172-8.
    View in: PubMed
    Score: 0.070
  40. Passive immunization with monoclonal antibodies against herpes simplex virus glycoproteins protects mice against herpetic ocular disease. Curr Eye Res. 1987 Jan; 6(1):173-7.
    View in: PubMed
    Score: 0.068
  41. Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumors. Cancer Gene Ther. 2007 Jan; 14(1):45-56.
    View in: PubMed
    Score: 0.067
  42. Studies on herpes simplex virus type 1 glycoproteins using monoclonal antibodies. Virology. 1986 Jun; 151(2):385-9.
    View in: PubMed
    Score: 0.065
  43. Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection. J Clin Microbiol. 1986 Apr; 23(4):725-30.
    View in: PubMed
    Score: 0.064
  44. A rabbit model of focal herpes simplex encephalitis. J Infect Dis. 1986 Apr; 153(4):732-5.
    View in: PubMed
    Score: 0.064
  45. Analysis of DNA from recurrent genital herpes simplex virus isolates by restriction endonuclease digestion. Sex Transm Dis. 1986 Apr-Jun; 13(2):61-6.
    View in: PubMed
    Score: 0.064
  46. Effect of cloned human interferons on protein synthesis and morphogenesis of herpes simplex virus. J Virol. 1985 Nov; 56(2):419-25.
    View in: PubMed
    Score: 0.063
  47. Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model. Neuro Oncol. 2005 Jul; 7(3):213-24.
    View in: PubMed
    Score: 0.061
  48. Herpes simplex encephalitis: children and adolescents. Semin Pediatr Infect Dis. 2005 Jan; 16(1):17-23.
    View in: PubMed
    Score: 0.059
  49. Dna restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N Engl J Med. 1982 Oct 21; 307(17):1060-2.
    View in: PubMed
    Score: 0.051
  50. Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications. Clin Microbiol Infect. 2002 Sep; 8(9):551-63.
    View in: PubMed
    Score: 0.050
  51. Herpes simplex virus infections. Lancet. 2001 May 12; 357(9267):1513-8.
    View in: PubMed
    Score: 0.046
  52. Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors. Cancer Res. 1999 May 01; 59(9):2055-8.
    View in: PubMed
    Score: 0.040
  53. Antiviral resistance: mechanisms, clinical significance, and future implications. J Antimicrob Chemother. 1996 Mar; 37(3):403-21.
    View in: PubMed
    Score: 0.032
  54. Assays for antiviral drug resistance. Antiviral Res. 1995 Apr; 26(4):403-13.
    View in: PubMed
    Score: 0.030
  55. Antiviral effect of the extract of culture medium of Lentinus edodes mycelia on the replication of herpes simplex virus type 1. Antiviral Res. 1993 Apr; 20(4):293-303.
    View in: PubMed
    Score: 0.026
  56. Effect of (S)-1-[(3-hydroxy-2-phosphonyl methoxy) propyl] cytosine on the replication and morphogenesis of herpes simplex virus type 1. Antiviral Res. 1992 Sep; 19(3):181-92.
    View in: PubMed
    Score: 0.025
  57. Evaluation of a test based on baculovirus-expressed glycoprotein G for detection of herpes simplex virus type-specific antibodies. J Infect Dis. 1991 Dec; 164(6):1196-9.
    View in: PubMed
    Score: 0.024
  58. Apical expression of herpes simplex virus type 2 glycoproteins in human neuroblastoma cells. Virology. 1991 Dec; 185(2):908-10.
    View in: PubMed
    Score: 0.024
  59. Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science. 1990 Nov 30; 250(4985):1262-6.
    View in: PubMed
    Score: 0.022
  60. In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus). J Infect Dis. 1990 Aug; 162(2):313-21.
    View in: PubMed
    Score: 0.022
  61. Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet. 1990 Feb 24; 335(8687):440-1.
    View in: PubMed
    Score: 0.021
  62. Individual NK cell clones lyse both tumor cell targets and herpes simplex virus-infected fibroblasts in the absence of interferon. Viral Immunol. 1990; 3(3):217-24.
    View in: PubMed
    Score: 0.021
  63. Immunological alterations associated with recurrent herpes simplex genitalis. Clin Immunol Immunopathol. 1989 May; 51(2):294-302.
    View in: PubMed
    Score: 0.020
  64. Identification of a herpes simplex virus 1 glycoprotein gene within a gene cluster dispensable for growth in cell culture. Proc Natl Acad Sci U S A. 1987 Jun; 84(12):4303-7.
    View in: PubMed
    Score: 0.017
  65. Detection of antibodies to herpes simplex virus in the cerebrospinal fluid of patients with herpes simplex encephalitis. J Infect Dis. 1987 Jan; 155(1):38-44.
    View in: PubMed
    Score: 0.017
  66. Protective immunity against herpetic ocular disease in an outbred mouse model. Curr Eye Res. 1987 Jan; 6(1):167-71.
    View in: PubMed
    Score: 0.017
  67. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986 Jan 16; 314(3):144-9.
    View in: PubMed
    Score: 0.016
  68. Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy. J Infect Dis. 1984 Sep; 150(3):323-9.
    View in: PubMed
    Score: 0.014
  69. Effect of cloned human interferons on the replication of and cell fusion induced by herpes simplex virus. Virus Res. 1984 Jan; 1(1):81-7.
    View in: PubMed
    Score: 0.014
  70. ELISA for the detection of herpes simplex virus antigens in the cerebrospinal fluid of patients with encephalitis. J Virol Methods. 1983 Sep; 7(3):117-25.
    View in: PubMed
    Score: 0.013
  71. Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis. 1982 Jun; 145(6):829-36.
    View in: PubMed
    Score: 0.012
  72. Herpes simplex encephalitis. Clinical Assessment. JAMA. 1982 Jan 15; 247(3):317-20.
    View in: PubMed
    Score: 0.012
  73. Rapid detection of viruses in biopsy or autopsy specimens by the pseudoreplica method of electron microscopy. Am J Surg Pathol. 1981 Sep; 5(6):565-72.
    View in: PubMed
    Score: 0.012
  74. Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med. 1981 Feb 05; 304(6):313-8.
    View in: PubMed
    Score: 0.011
  75. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics. 1980 Oct; 66(4):489-94.
    View in: PubMed
    Score: 0.011
  76. Purification and characterization of proteins excreted by cells infected with herpes simplex virus and their use in diagnosis. Virology. 1978 Dec; 91(2):234-42.
    View in: PubMed
    Score: 0.010
  77. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977 Aug 11; 297(6):289-94.
    View in: PubMed
    Score: 0.009
  78. Effect of adenine arabinoside on severe Herpesvirus hominis infections in man. J Infect Dis. 1973 Nov; 128(5):658-63.
    View in: PubMed
    Score: 0.007
  79. Humanized antibodies for antiviral therapy. Proc Natl Acad Sci U S A. 1991 Apr 01; 88(7):2869-73.
    View in: PubMed
    Score: 0.006
  80. Experience with brain biopsy for suspected herpes encephalitis: a review of forty consecutive cases. Neurosurgery. 1983 Jun; 12(6):654-7.
    View in: PubMed
    Score: 0.003
  81. Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired early in infancy. Infect Immun. 1981 Oct; 34(1):166-70.
    View in: PubMed
    Score: 0.003
  82. Productive infection with cytomegalovirus and herpes simplex virus in renal transplant recipients: role of source of kidney. J Infect Dis. 1978 May; 137(5):556-63.
    View in: PubMed
    Score: 0.002
  83. Antiviral chemotherapy and neonatal herpes simplex virus infecition: a pilot study--experience with adenine arabinoside (ARA-A). Pediatrics. 1975 May; 55(5):678-85.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.